Bemcentinib
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for Bemcentinib, covering 2021-11-09 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: Study of Bemcentinib Plus Pacritinib In Patients With Advanced Lung Adenocarcinoma [Phase 1, Phase 2]